Mucosal Immunology

Scope & Guideline

Connecting Science and Mucosal Health

Introduction

Welcome to your portal for understanding Mucosal Immunology, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1933-0219
PublisherELSEVIER SCIENCE INC
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 2008 to 2024
AbbreviationMUCOSAL IMMUNOL / Mucosal Immunol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressSTE 800, 230 PARK AVE, NEW YORK, NY 10169

Aims and Scopes

Mucosal Immunology focuses on the intricate interactions between the immune system and mucosal surfaces, highlighting the role of mucosal immunity in health and disease. It encompasses a range of research areas, primarily emphasizing the mechanisms that regulate immune responses at mucosal sites, the implications of microbiota on immune function, and the pathogenesis of mucosal diseases.
  1. Mucosal Immune Responses:
    The journal investigates how the immune system operates at mucosal surfaces, emphasizing the roles of various immune cells, including T cells, B cells, and innate lymphoid cells, in mediating protective responses against pathogens.
  2. Microbiota and Mucosal Immunity:
    Research on the interactions between the microbiota and the immune system is a core focus, exploring how microbial communities influence immune responses and contribute to conditions such as inflammatory bowel disease and allergies.
  3. Pathogenesis of Mucosal Diseases:
    The journal covers studies on the mechanisms underlying mucosal diseases, including inflammatory bowel disease, allergies, and infections, providing insights into potential therapeutic approaches.
  4. Innovative Therapeutic Strategies:
    Mucosal Immunology also emphasizes the development of novel therapeutic strategies targeting mucosal immunity, including vaccines and immunotherapies aimed at enhancing mucosal responses.
  5. Single-cell and Transcriptomic Analyses:
    Utilizing advanced methodologies such as single-cell RNA sequencing and transcriptomic profiling, the journal presents cutting-edge research that uncovers the complexities of immune cell interactions and functions at mucosal sites.
Recent publications in Mucosal Immunology indicate the emergence of several key themes that reflect current trends and areas of growing interest within the field. These themes are significant for advancing our understanding of mucosal immunity and developing novel therapeutic approaches.
  1. Impact of SARS-CoV-2 on Mucosal Immunity:
    Research examining the effects of SARS-CoV-2 on mucosal immunity has surged, focusing on the interplay between viral infection and mucosal immune responses, as well as implications for vaccination and disease outcomes.
  2. Single-Cell Immunology:
    There is a growing trend towards utilizing single-cell technologies to dissect the heterogeneity of immune responses at mucosal surfaces, providing insights into cell-specific functions and interactions.
  3. Metabolic Regulation of Mucosal Immunity:
    Emerging studies are highlighting the role of metabolic pathways in regulating mucosal immune responses, suggesting that metabolism plays a critical role in immune cell function and inflammation.
  4. Therapeutics Targeting Gut Microbiota:
    Research focusing on microbiota-targeted therapies, including probiotics and dietary interventions, is on the rise as scientists explore their potential to modulate mucosal immunity and treat related diseases.
  5. Regulatory T Cell Dynamics:
    The dynamics of regulatory T cells in maintaining mucosal homeostasis and their potential therapeutic applications are increasingly emphasized, reflecting a heightened interest in immune tolerance mechanisms.

Declining or Waning

While Mucosal Immunology continues to evolve, certain themes have shown a decline in focus over recent years. These waning scopes reflect shifting interests within the field, possibly influenced by emerging research priorities or advancements in related areas.
  1. Traditional Vaccine Approaches:
    Research focusing solely on traditional vaccine approaches for systemic immunity has become less prominent, with a shift towards understanding mucosal vaccination strategies that leverage the unique properties of mucosal immune responses.
  2. Basic Descriptive Studies:
    There is a noticeable decline in purely descriptive studies of mucosal immune responses without mechanistic insights. The trend is moving towards studies that integrate functional analyses and therapeutic implications.
  3. Solely Host-Centric Immunology:
    Research that focuses solely on host immune responses without considering the role of microbiota and environmental factors is becoming less common, as the interplay between host and microbiome is increasingly recognized as crucial.
  4. Overemphasis on Inflammation:
    Studies that primarily emphasize inflammatory processes without exploring regulatory mechanisms or homeostasis in mucosal immunity seem to be declining, as the field shifts towards a more balanced understanding of immune regulation.

Similar Journals

INTERNATIONAL REVIEWS OF IMMUNOLOGY

Pioneering Discoveries in Immune Science
Publisher: TAYLOR & FRANCIS INCISSN: 0883-0185Frequency: 6 issues/year

INTERNATIONAL REVIEWS OF IMMUNOLOGY, published by Taylor & Francis Inc, is a leading academic journal that has been a cornerstone of immunological research since its inception in 1986. With an impressive impact factor and ranked in the top quartiles of its field (Q2 in both Immunology and Allergy), this journal offers a critical platform for the dissemination of influential findings and advancements within immunology. Spanning a diverse array of topics, from basic immune mechanisms to clinical applications, it aims to support the global scientific community in enhancing immunological understanding and therapeutic interventions. Researchers and professionals alike benefit from insights provided by renowned contributors, ensuring that the journal remains relevant in a rapidly evolving field. Directly accessible through subscription or institutional access, INTERNATIONAL REVIEWS OF IMMUNOLOGY is committed to fostering collaboration and innovation, making it an essential resource for anyone involved in immunological research and practice.

HUMAN IMMUNOLOGY

Unveiling the Complexities of Human Immunology
Publisher: ELSEVIER SCIENCE INCISSN: 0198-8859Frequency: 12 issues/year

HUMAN IMMUNOLOGY, published by Elsevier Science Inc, serves as a critical platform for disseminating research in the fields of immunology and allergy, as well as various aspects of miscellaneous medicine since its inception in 1980. With an ISSN of 0198-8859 and E-ISSN 1879-1166, this journal is pivotal for researchers and practitioners looking to advance their understanding of human immune responses and related conditions. The journal currently holds a respectable position within its field, as highlighted by its 2023 Scopus ranks—#114/233 in Immunology and Allergy and #132/236 in Immunology and Microbiology. Moreover, it maintains a Q2 quartile ranking in both Immunology and Allergy and miscellaneous Medicine, underscoring its influence and reach within the scientific community. Although it does not currently offer Open Access options, HUMAN IMMUNOLOGY remains dedicated to providing valuable insights and fostering academic discourse within its discipline, characterized by a rigorous peer-review process and a focus on innovative research trajectories.

CELLULAR IMMUNOLOGY

Connecting Scholars in Cellular Immunology
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0008-8749Frequency: 12 issues/year

CELLULAR IMMUNOLOGY is a prestigious journal published by Academic Press Inc. Elsevier Science, dedicated to advancing the field of immunology. Established in 1970 and converging ongoing research up to 2024, this journal has carved out a significant niche within the academic community, boasting a notable Q2 ranking in the Immunology category and holding a respectable 67th percentile ranking within Scopus for its contributions to the disciplines of Immunology and Microbiology. The journal serves as a vital platform for disseminating high-quality research, reviews, and methodologies that elucidate the intricacies of cellular immune responses, thereby benefiting researchers, professionals, and students alike. Although it does not offer open access, the journal's impact is evidenced by its comprehensive coverage of pioneering studies and ongoing developments in the immunological sciences, positioning it as an essential resource for those seeking to deepen their understanding and engage with the latest findings in cellular immunology.

JOURNAL OF IMMUNOLOGY

Exploring Breakthroughs in Immune Science
Publisher: AMER ASSOC IMMUNOLOGISTSISSN: 0022-1767Frequency: 24 issues/year

Welcome to the JOURNAL OF IMMUNOLOGY, a prestigious publication associated with the American Association of Immunologists and dedicated to advancing the field of immunology. With a rich history dating back to 1945, this journal is renowned for its high-impact research, evident in its notable 2023 Q1 rankings in both Immunology and Allergy, as well as its strong positions in Scopus rankings—Rank #68 in Immunology and Allergy and Rank #79 in Immunology and Microbiology. Although it operates on a subscription basis, its commitment to publishing cutting-edge studies ensures that it remains a vital resource for scientists, healthcare professionals, and students alike. As the journal continues to pave the way for innovative research and breakthroughs in immunological science, it facilitates a platform for dialogue and discovery among researchers and practitioners across the globe.

PARASITE IMMUNOLOGY

Fostering Collaboration in Immunology and Parasitology.
Publisher: WILEYISSN: 0141-9838Frequency: 12 issues/year

PARASITE IMMUNOLOGY, published by Wiley, is a leading journal in the field of immunology and parasitology, with an ISSN of 0141-9838 and E-ISSN of 1365-3024. Since its inception in 1979, it has played a pivotal role in advancing our understanding of host-parasite interactions, immunological responses to parasitic infections, and the mechanisms of immunological resistance. The journal is adeptly positioned within the academic community, currently holding a prestigious Q2 ranking in Parasitology and a Q3 ranking in Immunology for 2023, indicating its significant influence and relevance. Its comprehensive scope attracts a diverse readership, contributing to the discourse surrounding novel therapeutic approaches and emerging challenges in parasitic diseases. With a consistent convergence of research until 2024, PARASITE IMMUNOLOGY is an essential resource for researchers, professionals, and students seeking to deepen their knowledge and foster collaboration in these dynamic fields. Although it is not an open-access journal, the insights shared within its pages are invaluable for shaping future research trajectories.

TRENDS IN IMMUNOLOGY

Navigating the Evolving Landscape of Immunology
Publisher: CELL PRESSISSN: 1471-4906Frequency: 12 issues/year

TRENDS IN IMMUNOLOGY, published by CELL PRESS, stands as a premier source of insights and developments within the field of immunology. With an ISSN of 1471-4906 and E-ISSN of 1471-4981, this journal has established a strong reputation, evidenced by its prestigious status in Q1 quartiles for both Immunology and Allergy in 2023. It is ranked #13 out of 233 in the Scopus category of Medicine – Immunology and Allergy, and #16 out of 236 in Immunology and Microbiology, placing it within the top 94th and 93rd percentiles respectively. Since its inception in 1987, TRENDS IN IMMUNOLOGY has provided a critical platform for researchers, professionals, and students to access the latest advancements and integrative reviews in immunological research. The journal offers open access options, enhancing the accessibility of its high-impact content to a global audience. Researchers and practitioners rely on its pages not only for cutting-edge findings but also for comprehensive discussions that drive the future of immunology research.

NATURE IMMUNOLOGY

Exploring the intricacies of the immune system for a healthier tomorrow.
Publisher: NATURE PORTFOLIOISSN: 1529-2908Frequency: 12 issues/year

NATURE IMMUNOLOGY is a premier academic journal published by NATURE PORTFOLIO, dedicated to advancing the field of immunology. With an impressive impact factor that reflects its esteemed position, this journal ranks in the top quartile (Q1) of renowned categories, including Immunology and Allergy. Serving as a crucial platform for researchers, professionals, and students, NATURE IMMUNOLOGY showcases cutting-edge research, comprehensive reviews, and insightful perspectives that drive innovation in immunological science. Based in the United Kingdom, this journal has been a vital contributor to the global discourse on immune responses and related diseases since its inception in 2000. Researchers can benefit from its rigorous peer-review process, ensuring that only high-quality studies are disseminated, thus enhancing their academic pursuits and practical applications. Explore the latest findings and trends within this flourishing discipline, making NATURE IMMUNOLOGY an essential resource for anyone engaged in the study of the immune system.

JOURNAL OF REPRODUCTIVE IMMUNOLOGY

Elevating research in reproductive health through immune perspectives.
Publisher: ELSEVIER IRELAND LTDISSN: 0165-0378Frequency: 6 issues/year

The JOURNAL OF REPRODUCTIVE IMMUNOLOGY, published by Elsevier Ireland Ltd, stands as a pivotal platform for exploring the intricate interactions between reproductive health and the immune system. With an ISSN of 0165-0378 and an E-ISSN of 1872-7603, this esteemed journal spans over four decades, from 1979 to 2024, contributing significantly to the fields of Immunology, Reproductive Medicine, and Obstetrics and Gynecology. Currently ranked in Q2 for Immunology and Allergy and Q1 for both Obstetrics and Gynecology and Reproductive Medicine, it serves as an invaluable resource for researchers, professionals, and students dedicated to advancing knowledge in reproductive health. The journal’s notable impact factor and rigorous peer-review process underscore its commitment to high-quality research, making it an essential reference point for ongoing studies in this ever-evolving discipline. By promoting interdisciplinary discussions and pioneering research findings, the JOURNAL OF REPRODUCTIVE IMMUNOLOGY fosters a deeper understanding of the immune mechanisms that influence reproductive outcomes.

Immunological Medicine

Empowering Innovation in Immunological Medicine
Publisher: TAYLOR & FRANCIS LTDISSN: Frequency: 4 issues/year

Immunological Medicine, published by Taylor & Francis Ltd, is an esteemed open-access journal that has made significant strides in the field of immunology since its establishment in 2018. With an E-ISSN of 2578-5826, the journal has quickly gained recognition for its contribution to advancing immunological research, evidenced by its impressive ranking in the Q2 quartile for both immunology and allergy. Positioned in the United Kingdom, it offers a platform for publishing high-quality original research, reviews, and case studies that delve into the complex interactions of the immune system and its implications for human health. The journal serves as a vital resource for researchers, professionals, and students engaged in the burgeoning fields of immunology, providing open access to a wide audience and fostering collaboration and innovation. With a current Scopus ranking of #81 out of 233 in Immunology and Allergy and #97 out of 236 in Immunology and Microbiology, the journal aims to enhance the visibility and impact of cutting-edge research by bridging the gap between academia and clinical practice.

Frontiers in Immunology

Shaping the Future of Immunology with Cutting-Edge Research
Publisher: FRONTIERS MEDIA SAISSN: 1664-3224Frequency: 1 issue/year

Frontiers in Immunology is a leading open-access journal published by FRONTIERS MEDIA SA since 2010, dedicated to advancing knowledge in the field of immunology. With an impressive Q1 ranking in both Immunology and Allergy as of 2023, this journal exemplifies excellence in research dissemination, positioning itself among the top 22% of relevant literature in the discipline. The journal, based in Switzerland, emphasizes its commitment to open science by ensuring all published research is freely accessible, fostering collaboration and innovation among researchers, professionals, and students alike. With substantial visibility demonstrated by its ranks within the Scopus database—ranked #52 out of 233 in Immunology and Allergy, and #58 out of 236 in Immunology and Microbiology—Frontiers in Immunology serves as a vital platform for cutting-edge research. Researchers are invited to contribute original investigations and reviews that expand the understanding of immune mechanisms, therapeutic advancements, and clinical applications, making it a cornerstone for those looking to push the boundaries of immunological science.